Marquez Megan, Boscan Pedro, Weir Heather, Vogel Pamela, Twedt David C
Department of Clinical Sciences, Veterinary Teaching Hospital, Colorado State University, Fort Collins, Colorado, United States of America.
PLoS One. 2015 Oct 29;10(10):e0140734. doi: 10.1371/journal.pone.0140734. eCollection 2015.
To compare the NK-1 receptor antagonist maropitant to morphine during and after surgery in dogs undergoing ovariohysterectomy (OHE).
30 healthy female dogs were randomly divided to receive either a pre-anaesthetic dose of morphine (0.5 mg/kg SQ) or maropitant (1 mg/kg, SQ) prior to OHE. Anaesthesia was induced with propofol and maintained with isoflurane. Expired isoflurane concentration, heart rate (HR), systolic arterial pressure (SAP) and respiratory rate were measured. Post-operative pain scores and appetite were evaluated during the recovery period. Rescue analgesia (morphine 0.1 mg/kg IV) was administered as needed post-operatively based on blinded pain score assessments.
Although clinically comparable; during surgical stimulation, the maropitant group had lower HR (108±18 vs 115±24 bpm; p = 0.04), lower SAP (114±23 vs 125±23 mmHg; p = 0.003) and required slightly lower percent of isoflurane anaesthetic (1.35±0.2 vs 1.51±0.4%; p = 0.005), when compared to the morphine group. In the recovery period, the maropitant group had lower pain scores at extubation (1.7±0.7 vs 3.4±2.3; p = 0.0001) and were more likely to eat within 3 hours after extubation (64.7 vs 15.3%). However, post-operative rescue analgesia requirements were similar between groups. All other measured parameters were similar between groups. The overall difference observed between groups was small and all monitored and measured parameters were within the expected range for anesthetized dogs.
No major differences in cardiorespiratory parameters or anaesthetic requirements were observed between maropitant and morphine when used as a pre-anesthetic agent for OHE. Further studies are necessary to fully elucidate the benefits of maropitant as a pre-anaesthetic agent for canine OHE.
比较NK-1受体拮抗剂马罗匹坦与吗啡在接受卵巢子宫切除术(OHE)的犬只手术期间及术后的效果。
30只健康雌性犬被随机分为两组,在OHE术前分别接受麻醉前剂量的吗啡(0.5mg/kg皮下注射)或马罗匹坦(1mg/kg,皮下注射)。用丙泊酚诱导麻醉,异氟烷维持麻醉。测量呼出的异氟烷浓度、心率(HR)、收缩压(SAP)和呼吸频率。在恢复期评估术后疼痛评分和食欲。根据盲法疼痛评分评估,术后按需给予解救镇痛(吗啡0.1mg/kg静脉注射)。
虽然在临床上具有可比性;但在手术刺激期间,与吗啡组相比,马罗匹坦组的HR较低(108±18对115±24次/分钟;p = 0.04),SAP较低(114±23对125±23mmHg;p = 0.003),所需异氟烷麻醉百分比略低(1.35±0.2对1.51±0.4%;p = 0.005)。在恢复期,马罗匹坦组拔管时的疼痛评分较低(1.7±0.7对3.4±2.3;p = 0.0001),且在拔管后3小时内进食的可能性更大(64.7对15.3%)。然而,两组术后解救镇痛的需求相似。两组之间所有其他测量参数相似。两组之间观察到的总体差异较小,所有监测和测量参数均在麻醉犬的预期范围内。
当用作OHE的麻醉前药物时,马罗匹坦和吗啡在心肺参数或麻醉需求方面未观察到重大差异。需要进一步研究以充分阐明马罗匹坦作为犬OHE麻醉前药物的益处。